The combination of IFF and DuPont’s Nutrition & Biosciences business will deliver significant value creation for shareholders of both companies through a well-established, tax-efficient Reverse Morris Trust structure, meaningful cash EPS accretion and significant revenue and cost synergy potential. We are committed to maintaining an investment grade credit rating, and the combined company will maintain IFF’s existing dividend policy.

“The value creation opportunity of this combination is significant as we can better serve our customers, provide greater growth opportunities for our employees and generate strong and attractive financial returns for our shareholders.”

Andreas Fibig, Chairman and CEO of IFF

Transaction Announcement Materials

Purpose, Vision, Operating Model and Executive Committee Announcement Materials

IFF Shareholders Approve Merger with DuPont's Nutrition & Biosciences Business

IFF Previews Financial Profile, Governance and Strategic Transformation Initiatives Effective at Completion of Combination with DuPont N&B

Investor Contacts

IFF Investor Relations
IFF Corporate IR Website
Michael DeVeau
[email protected]

DuPont Investor Relations
DuPont Corporate IR Website
Leland Weaver
[email protected]